EUVIMEDEUVIMED entdecken
Crossref

Improved oral bioavailability of febuxostat by liquid self-micro emulsifying drug delivery system in capsule shells

Vaishali Londhe, Pooja Bakshi

Annales Pharmaceutiques Françaises · 2023

DOI: 10.1016/j.pharma.2023.05.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2023. Verfasst von Vaishali Londhe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Vile Parle [W], 400056 Mumbai, Maharashtra, India. Electronic ad…. Hauptthemen laut MEDLINE: Febuxostat, Gelatin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Febuxostat is a non-purine xanthine oxidase inhibitor which belongs to the BCS class II. Main aim of this study is to enhance dissolution and bioavailability of a drug by formulating a liquid self-micro emulsifying drug delivery system (SMEDDS) in different capsule shells. METHOD: Compatability of gelatin and cellulose capsule shells was checked with different oils, surfactants and co-surfactants. Solubility studies were then carried out in selected excipients. Capryol 90, labrasol, and PEG 400 were used in a liquid SMEDDS formulation based on phase diagram and the drug loading. Further SMEDDS was characterized for zeta potential, globule size and shape, thermal stability and in vitro release. Based on the in vitro release, pharmacokinetic study was carried out using SMEDDS in gelatin capsule shells. RESULT: The diluted SMEDDS had globule size of 157.9±1.5d.nm, zeta potential of -16.2±0.4mV and they were thermodynamically stable. The formulation was found stable for 12 months in capsule shells. When tested in different media (0.1N HCl and pH 4.5 acetate buffer), the in vitro release of newly produced formulations differed substantially from that of commercially available tablets, while the release rate in alkaline medium (pH 6.8) was comparable and the highest. According to in vivo findings in rats, a threefold increase in plasma concentration, a fourfold increase in AUC0-t, and a reduction in oral clearance increased fuxostat's oral bioavailability. CONCLUSION: This investigation revealed that the novel liquid SMEDDS formulation sealed in capsules has considerable potential as a vehicle for enhancing the bioavailability of febuxostat.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FebuxostatGelatinRatsAnimalsBiological AvailabilityEmulsionsChemistry, PharmaceuticalDrug Delivery SystemsSurface-Active AgentsSolubilityExcipientsAdministration, OralParticle Size

Stichwörter der Autor:innen

Biodisponibilité orale.Cellulose capsule shellsEnveloppes de capsules celluloseEnveloppes de capsules de gélatineFebuxostatGelatin capsule shellsOral bioavailabilityPharmacocinétiquePharmacokineticsSMEDDS

Substanzen

FebuxostatGelatinEmulsionsSurface-Active AgentsExcipients

Autor:innen und Institutionen

  • Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Vile Parle [W], 400056 Mumbai, Maharashtra, India. Electronic address: vaishali_londhe2000@yahoo.com.
  • Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Vile Parle [W], 400056 Mumbai, Maharashtra, India.

Zitieren

APA

Londhe, V., & Bakshi, P. (2023). Improved oral bioavailability of febuxostat by liquid self-micro emulsifying drug delivery system in capsule shells. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2023.05.003

Vancouver

Londhe V, Bakshi P. Improved oral bioavailability of febuxostat by liquid self-micro emulsifying drug delivery system in capsule shells. Annales Pharmaceutiques Françaises. 2023. doi:10.1016/j.pharma.2023.05.003

BibTeX
@article{Londhe2023,
  author = {Londhe, Vaishali and Bakshi, Pooja},
  title = {Improved oral bioavailability of febuxostat by liquid self-micro emulsifying drug delivery system in capsule shells},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2023},
  doi = {10.1016/j.pharma.2023.05.003}
}
Kostenlos starten →